Auctus Capital Partners is gearing up for a sale of PharmaLex Group, a Germany-based global pharma services platform, four sources tell Axios.
Why it matters: The rapid development of new therapies and their increasing complexity, along with the shift to more targeted drug marketing spend, is driving up demand for pharma commercialization and clinical development services.
